Ticagrelor: The First Reversibly Binding Oral P2Y(12) Receptor Antagonist

Ticagrelor (AZD6140) is the first reversibly binding oral P2Y(12) receptor antagonist that blocks ADP-induced platelet aggregation. Unlike thienopyridines, which irreversibly bind to the P2Y(12) receptor for the lifetime of the platelet, ticagrelor binds reversibly to the receptor and exhibits rapid...

Descripción completa

Detalles Bibliográficos
Autores principales: Husted, Steen, van Giezen, JJJ
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948430/
https://www.ncbi.nlm.nih.gov/pubmed/19604248
http://dx.doi.org/10.1111/j.1755-5922.2009.00096.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948430/
https://www.ncbi.nlm.nih.gov/pubmed/19604248
http://dx.doi.org/10.1111/j.1755-5922.2009.00096.x

Ejemplares similares